These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 17310925

  • 21. Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis.
    Millar BC, Prendergast BD, Moore JE.
    J Antimicrob Chemother; 2008 Jan; 61(1):1-7. PubMed ID: 17962214
    [Abstract] [Full Text] [Related]

  • 22. In vitro activities of 28 antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) from a clinical setting in Malaysia.
    Neela V, Sasikumar M, Ghaznavi GR, Zamberi S, Mariana S.
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):885-92. PubMed ID: 19058585
    [Abstract] [Full Text] [Related]

  • 23. Chitosan-based rechargeable long-term antimicrobial and biofilm-controlling systems.
    Cao Z, Sun Y.
    J Biomed Mater Res A; 2009 Jun 15; 89(4):960-7. PubMed ID: 18470925
    [Abstract] [Full Text] [Related]

  • 24. Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection.
    Proctor RA.
    Clin Infect Dis; 2008 Feb 15; 46(4):584-93. PubMed ID: 18197761
    [Abstract] [Full Text] [Related]

  • 25. Comment on: unexpected antimicrobial effect of statins.
    Nalin DR.
    J Antimicrob Chemother; 2008 Jun 15; 61(6):1400. PubMed ID: 18321843
    [No Abstract] [Full Text] [Related]

  • 26. Evaluation of different nucleic acid amplification techniques for the detection of M. pneumoniae, C. pneumoniae and Legionella spp. in respiratory specimens from patients with community-acquired pneumonia.
    Loens K, Beck T, Ursi D, Overdijk M, Sillekens P, Goossens H, Ieven M.
    J Microbiol Methods; 2008 Jun 15; 73(3):257-62. PubMed ID: 18378345
    [Abstract] [Full Text] [Related]

  • 27. Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study.
    Tillotson GS, Draghi DC, Sahm DF, Tomfohrde KM, Del Fabro T, Critchley IA.
    J Antimicrob Chemother; 2008 Jul 15; 62(1):109-15. PubMed ID: 18397923
    [Abstract] [Full Text] [Related]

  • 28. Methicillin resistant Staphylococcus aureus in cystic fibrosis.
    Taccetti G, Neri AS, Festini F, Galici V, Cocchi P, Campana S.
    Pediatr Pulmonol; 2008 Mar 15; 43(3):309; author reply 310. PubMed ID: 18214947
    [No Abstract] [Full Text] [Related]

  • 29. Current challenges in treating MRSA: what are the options?
    Ratnaraja NV, Hawkey PM.
    Expert Rev Anti Infect Ther; 2008 Oct 15; 6(5):601-18. PubMed ID: 18847401
    [Abstract] [Full Text] [Related]

  • 30. Methicillin-resistant Staphylococcus aureus: an evolving clinical challenge.
    Karchmer AW, Bayer AS.
    Clin Infect Dis; 2008 Jun 01; 46 Suppl 5():S342-3. PubMed ID: 18462088
    [No Abstract] [Full Text] [Related]

  • 31. [Methicillin-resistant Staphylococcus aureus (MRSA) in the community].
    Vonk AG, Vandenbroucke-Grauls CM.
    Ned Tijdschr Geneeskd; 2007 Feb 17; 151(7):401-7. PubMed ID: 17343138
    [Abstract] [Full Text] [Related]

  • 32. Linezolid for tympanostomy tube otorrhea caused by methicillin-resistant Staphylococcus aureus and multiple drug-resistant Streptococcus pneumoniae.
    Isaacson G, Aronoff SC.
    Int J Pediatr Otorhinolaryngol; 2008 May 17; 72(5):647-51. PubMed ID: 18321598
    [Abstract] [Full Text] [Related]

  • 33. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
    Laupland KB, Ross T, Gregson DB.
    J Infect Dis; 2008 Aug 01; 198(3):336-43. PubMed ID: 18522502
    [Abstract] [Full Text] [Related]

  • 34. Susceptibilities of healthcare- and community-associated methicillin-resistant staphylococci to the novel des-F(6)-quinolone DX-619.
    Watanabe S, Ito T, Hiramatsu K.
    J Antimicrob Chemother; 2007 Dec 01; 60(6):1384-7. PubMed ID: 17890283
    [Abstract] [Full Text] [Related]

  • 35. Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria.
    Raad I, Reitzel R, Jiang Y, Chemaly RF, Dvorak T, Hachem R.
    J Antimicrob Chemother; 2008 Oct 01; 62(4):746-50. PubMed ID: 18653489
    [Abstract] [Full Text] [Related]

  • 36. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK.
    Semin Respir Crit Care Med; 2007 Dec 01; 28(6):632-45. PubMed ID: 18095227
    [Abstract] [Full Text] [Related]

  • 37. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
    Scheinfeld N.
    J Drugs Dermatol; 2007 Jan 01; 6(1):97-103. PubMed ID: 17373167
    [Abstract] [Full Text] [Related]

  • 38. [The molecular characteristic of Staphylococcus aureus and Staphylococcus epidermidis strains isolated from clinical sources].
    Zdzalik D, Dominiak A, Gałkowska H, Interewicz B, Olszewski WL, Stelmach E, Luczak M, Machowski Z.
    Med Dosw Mikrobiol; 2006 Jan 01; 58(4):269-74. PubMed ID: 17642304
    [Abstract] [Full Text] [Related]

  • 39. Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.
    Sparo MD, Jones DG, Sánchez Bruni SF.
    Chemotherapy; 2009 Jan 01; 55(4):270-7. PubMed ID: 19494489
    [Abstract] [Full Text] [Related]

  • 40. Community-associated methicillin-resistant Staphylococcus aureus (MRSA) is replacing traditional health care-associated MRSA strains in surgical-site infections among inpatients.
    Manian FA, Griesnauer S.
    Clin Infect Dis; 2008 Aug 01; 47(3):434-5. PubMed ID: 18605916
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.